Recent Finacing
Recent Raise
Normunity is a biotech company developing immuno-oncology therapies, including T-cell engager NRM-823 targeting a tumor-specific antigen, plus antibodies, bispecifics, ADCs, and radiotheranostics via Yale collaboration.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Normunity.
